Formerly CEO of Hubbard / ISA (multinational poultry genetics firm); formerly global head of legal and regulatory affairs at Merial (now part of Boehringer Ingelheim Vetmedica). Previously at Merck. BA, Harvard; J.D.: Penn.

Formerly head of Business Development and Strategy at Merial (company described above). Managed multiple investment decisions in early and late stage animal health technologies. Previously at Merck. B.S., Purdue; MBA South Carolina.